A detailed history of Israel Englander (Millennium Management LLC) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Millennium Management LLC holds 140,537 shares of CSTL stock, worth $4.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140,537
Previous 460,000 69.45%
Holding current value
$4.19 Million
Previous $10 Million 59.98%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.4 - $31.47 $1.84 Million - $3.33 Million
105,710 Added 303.53%
140,537 $4.01 Million
Q2 2024

Aug 14, 2024

SELL
$18.84 - $24.94 $4.03 Million - $5.33 Million
-213,726 Reduced 85.99%
34,827 $758,000
Q1 2024

May 15, 2024

SELL
$18.06 - $25.3 $8.45 Million - $11.8 Million
-467,797 Reduced 65.3%
248,553 $5.51 Million
Q4 2023

Feb 14, 2024

SELL
$12.19 - $22.43 $3.89 Million - $7.16 Million
-319,243 Reduced 30.83%
716,350 $15.5 Million
Q2 2023

Aug 14, 2023

BUY
$11.66 - $26.0 $2.45 Million - $5.46 Million
210,156 Added 25.46%
1,035,593 $14.2 Million
Q1 2023

May 15, 2023

SELL
$19.47 - $28.49 $1.71 Million - $2.51 Million
-87,938 Reduced 9.63%
825,437 $18.8 Million
Q4 2022

Feb 14, 2023

SELL
$18.08 - $30.0 $885,305 - $1.47 Million
-48,966 Reduced 5.09%
913,375 $21.5 Million
Q3 2022

Nov 14, 2022

BUY
$22.51 - $34.32 $1.36 Million - $2.07 Million
60,252 Added 6.68%
962,341 $25.1 Million
Q2 2022

Aug 15, 2022

BUY
$16.0 - $45.99 $10.1 Million - $28.9 Million
629,448 Added 230.87%
902,089 $19.8 Million
Q1 2022

May 16, 2022

SELL
$33.17 - $46.98 $8.09 Million - $11.5 Million
-243,865 Reduced 47.21%
272,641 $12.2 Million
Q4 2021

Feb 14, 2022

BUY
$39.06 - $67.58 $4.42 Million - $7.65 Million
113,147 Added 28.05%
516,506 $22.1 Million
Q3 2021

Nov 15, 2021

BUY
$60.13 - $77.6 $24.3 Million - $31.3 Million
403,359 New
403,359 $26.8 Million
Q2 2021

Aug 16, 2021

SELL
$50.07 - $76.78 $12.5 Million - $19.2 Million
-250,070 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$58.92 - $97.33 $13.7 Million - $22.7 Million
-233,209 Reduced 48.26%
250,070 $17.1 Million
Q4 2020

Feb 16, 2021

BUY
$43.6 - $73.05 $5.6 Million - $9.39 Million
128,548 Added 36.24%
483,279 $32.5 Million
Q3 2020

Nov 16, 2020

BUY
$38.47 - $52.03 $261,711 - $353,960
6,803 Added 1.96%
354,731 $18.3 Million
Q2 2020

Aug 14, 2020

BUY
$27.28 - $43.01 $3.78 Million - $5.96 Million
138,479 Added 66.12%
347,928 $13.1 Million
Q1 2020

May 14, 2020

BUY
$23.08 - $35.53 $4.83 Million - $7.44 Million
209,449 New
209,449 $6.24 Million
Q4 2019

Feb 14, 2020

SELL
$15.74 - $35.04 $2.45 Million - $5.45 Million
-155,538 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$18.09 - $27.92 $2.81 Million - $4.34 Million
155,538 New
155,538 $2.81 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $784M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.